AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14513073 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-substituted diet (FS) containing olestra (33% lipid and 25% digestible fat)
Number of subjects: 37
Study 14513073 — intervention group
Group type: COMPARATOR
Intervention: Control diet (33% fat)
Number of subjects: 37
Study 14513073 — intervention group
Group type: COMPARATOR
Intervention: Fat-reduced diet (FR; 25% fat)
Number of subjects: 37
Study 14513073 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including FS, FR, and control)
Number of subjects: 37
Study 10904510 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (12.5 mg/d of chlorthalidone, with possible addition of 25 mg/d of atenolol or 0.05 mg/d of reserpine)
Number of subjects: 4736
Study 10904510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4736
Study 10904510 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 4736
Study 9054818 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with hyperlipidemia (case subjects)
Number of subjects: 52
Study 9054818 — intervention group
Group type: COMPARATOR
Intervention: Children in the cross-sectional component
Number of subjects: 52
Study 9054818 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers of children with hyperlipidemia
Number of subjects: 52
Study 9054818 — intervention group
Group type: COMPARATOR
Intervention: Mothers of children in the control group
Number of subjects: 52
Study 8439209 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g ampicillin-sulbactam (2 g ampicillin-1 g sulbactam), every 6 hours
Number of subjects: 385
Study 8439209 — intervention group
Group type: COMPARATOR
Intervention: 2 g cefoxitin, every 6 hours
Number of subjects: 385
Study 3712636 — intervention group
Group type: EXPERIMENTAL
Intervention: Protamine (0.75 mg/kg/3 min)
Number of subjects: 15
Study 3712636 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (n = 8)
Number of subjects: 15
Study 31596971 — intervention group
Group type: EXPERIMENTAL
Intervention: Team handball training without prior experience (UN)
Number of subjects: 32
Study 31596971 — intervention group
Group type: EXPERIMENTAL
Intervention: Team handball training with prior experience (EXP)
Number of subjects: 32
Study 31596971 — intervention group
Group type: COMPARATOR
Intervention: Inactive control group (CON)
Number of subjects: 32
Study 29931180 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative clinical staging model comprising VolCT and Fmax
Number of subjects: 472
Study 29931180 — intervention group
Group type: COMPARATOR
Intervention: cTNM staging
Number of subjects: 472
Study 28039798 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches (5-week supply)
Number of subjects: 500
Study 25583272 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care education program
Number of subjects: 378
Study 24005123 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation phase cognitive therapy (C‐CT)
Number of subjects: 241
Study 24005123 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 241
Study 24005123 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo (PBO)
Number of subjects: 241
Study 19940798 — intervention group
Group type: EXPERIMENTAL
Intervention: CTI + EI without the aid of fluoroscopy
Number of subjects: 53
Study 19940798 — intervention group
Group type: COMPARATOR
Intervention: CTI
Number of subjects: 53
Study 18431480 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination with live attenuated yellow fever 17D vaccine at a reduced dose (1/5th; 0.1 mL)
Number of subjects: 175
Study 18431480 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous vaccination with live attenuated yellow fever 17D vaccine (0.5 mL)
Number of subjects: 175
Study 18431480 — intervention group
Group type: EXPERIMENTAL
Intervention: In previously vaccinated individuals
Number of subjects: 175
Study 18431480 — intervention group
Group type: EXPERIMENTAL
Intervention: Viraemia measurement
Number of subjects: 175
Study 17205821 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolving phlegm method (RPM) using Chinese herbs (Indigo Naturalis 10 g, Alumen 3 g, Semen Cassiae 15 g, Fructus Crataegi 15 g, vinegar prepared Radix Bupleuri 10 g, Radix Curcumae 10 g, Radix Salviae Miltiorrhizae 12 g, Herba Lycopi 12 g, talc 12 g, Radix Glycyrrhizae 2 g), one dose twice per day orally for 12 weeks
Number of subjects: 62
Study 17205821 — intervention group
Group type: COMPARATOR
Intervention: Ursodeoxycholic acid tablet (UAT) 150 mg three times per day for 12 weeks
Number of subjects: 62
Study 12557834 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil 40 microg kg(‐1) followed by propofol 2 mg kg(‐1)
Number of subjects: 80
Study 12557834 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 2 microg kg(‐1) followed by propofol 2 mg kg(‐1)
Number of subjects: 80
Study 12557834 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 3 microg kg(‐1) followed by propofol 2 mg kg(‐1)
Number of subjects: 80
Study 12557834 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 4 microg kg(‐1) followed by propofol 2 mg kg(‐1)
Number of subjects: 80
Study 10694780 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 % of energy trans alpha‐linolenic acid for 6 weeks
Number of subjects: 88
Study 10694780 — intervention group
Group type: COMPARATOR
Intervention: Low trans alpha‐linolenic acid diet for 6 weeks
Number of subjects: 88
Study 8899093 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole plus amoxycillin (lansoprazole 30 mg o.m. for 6 or 8 weeks + amoxycillin 500 mg q.d.s. for the first 2 weeks)
Number of subjects: 119
Study 8899093 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole alone (30 mg o.m. for 6 or 8 weeks)
Number of subjects: 119
Study 1985415 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dosage antioxidants (tocopherol and ascorbate)
Number of subjects: 0
Study 1985415 — intervention group
Group type: COMPARATOR
Intervention: Control group (not taking antioxidants)
Number of subjects: 0
Study 6630556 — intervention group
Group type: EXPERIMENTAL
Intervention: examiner praise
Number of subjects: 51
Study 6630556 — intervention group
Group type: EXPERIMENTAL
Intervention: neutral feedback
Number of subjects: 51
Study 6630556 — intervention group
Group type: EXPERIMENTAL
Intervention: token reinforcement
Number of subjects: 51
Study 30253206 — intervention group
Group type: EXPERIMENTAL
Intervention: Pavlovian system activity measured with cue-reactivity task
Number of subjects: 30
Study 30253206 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed system activity measured with food-specific delay discounting paradigm
Number of subjects: 30
Study 30253206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-paradigm network analysis integrating both tasks
Number of subjects: 30
Study 29228438 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dezocine (0.05 mg/kg)
Number of subjects: 76
Study 29228438 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose dezocine (0.1 mg/kg)
Number of subjects: 76
Study 29228438 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dezocine (0.15 mg/kg)
Number of subjects: 76
Study 29228438 — intervention group
Group type: COMPARATOR
Intervention: Control (fentanyl: 10 μg/kg)
Number of subjects: 76
Study 25390761 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg daily (n = 18, 7 males)
Number of subjects: 37
Study 25390761 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 160 mg daily (n = 19, 3 males)
Number of subjects: 37
Study 23523985 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental imagery-based interventions
Number of subjects: 0
Study 21851836 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke-free campus policy
Number of subjects: 3266
Study 19834427 — intervention group
Group type: EXPERIMENTAL
Intervention: Mangafodipir (5 micromol/kg body weight)
Number of subjects: 7
Study 18046062 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 65
Study 14977896 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg intravaginal prostaglandin E(2) gel
Number of subjects: 36
Study 14977896 — intervention group
Group type: COMPARATOR
Intervention: K‐Y jelly (placebo)
Number of subjects: 36
Study 11697308 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitremer
Number of subjects: 200
Study 11697308 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketac-Bond
Number of subjects: 200
Study 11697308 — intervention group
Group type: COMPARATOR
Intervention: Control group (unsealed molars)
Number of subjects: 200
Study 10205922 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfur salt-bromine-iodine thermal waters
Number of subjects: 50
Study 10205922 — intervention group
Group type: COMPARATOR
Intervention: distilled water (placebo)
Number of subjects: 50
Study 9081851 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg micronized form of fenofibrate
Number of subjects: 0
Study 9081851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2081243 — intervention group
Group type: EXPERIMENTAL
Intervention: Large commemorative stamp
Number of subjects: 0
Study 2081243 — intervention group
Group type: EXPERIMENTAL
Intervention: Business-reply stamp
Number of subjects: 0
Study 2081243 — intervention group
Group type: COMPARATOR
Intervention: No stamp, metered stamp, small regular stamp
Number of subjects: 0
Study 6774674 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine nerve blocks intraoperatively
Number of subjects: 31
Study 6774674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent nerve blocks with bupivacaine
Number of subjects: 31
Study 6774674 — intervention group
Group type: COMPARATOR
Intervention: No nerve blocks (Control)
Number of subjects: 31
Study 31690402 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 977
Study 31690402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 977
Study 31690402 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin and Placebo
Number of subjects: 977
Study 29290275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold gel pad application for 20 minutes in the postpartum first 2 hours and 4 hours after the first application
Number of subjects: 200
Study 29290275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold gel pad application
Number of subjects: 200
Study 26317662 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 45
Study 26317662 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular Dose of Echinacea-Based Supplement (RD)
Number of subjects: 45
Study 26317662 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Dose of Echinacea-Based Supplement (DD)
Number of subjects: 45
Study 24673056 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated-dose group (30 cases) - heat-sensitive moxibustion until disappearance of heat-sensitive feeling, treated twice a day for 5 days, then once a day for 30 days.
Number of subjects: 60
Study 24673056 — intervention group
Group type: COMPARATOR
Intervention: Traditional-dose group (30 cases) - heat-sensitive moxibustion for 15 minutes each time, treated twice a day for 5 days, then once a day for 30 days.
Number of subjects: 60
Study 22174391 — intervention group
Group type: EXPERIMENTAL
Intervention: diet + aerobic
Number of subjects: 97
Study 22174391 — intervention group
Group type: COMPARATOR
Intervention: diet only
Number of subjects: 97
Study 22174391 — intervention group
Group type: COMPARATOR
Intervention: diet + resistance
Number of subjects: 97
Study 20725056 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol monotherapy
Number of subjects: 4703
Study 20725056 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine monotherapy
Number of subjects: 4703
Study 20725056 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol with added diuretic (second-line therapy)
Number of subjects: 4703
Study 20725056 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine with added perindopril (second-line therapy)
Number of subjects: 4703
Study 18303278 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive measures including fluoride varnish applications, mouthrinsing with 0.12% chlorhexine digluconate, professional oral hygiene.
Number of subjects: 180
Study 18303278 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 180
Study 18303278 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (preventive measures applied).
Number of subjects: 180
Study 16269029 — intervention group
Group type: EXPERIMENTAL
Intervention: LongoVital (LV)
Number of subjects: 60
Study 16269029 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbs of LongoVital
Number of subjects: 60
Study 16269029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12079956 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle-sparing thoracotomy technique
Number of subjects: 0
Study 9212134 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine + Sufentanil (Group 2)
Number of subjects: 100
Study 9212134 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (Group 1)
Number of subjects: 100
Study 9212134 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 100
Study 8306005 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials with 'significant' results
Number of subjects: 293
Study 8306005 — intervention group
Group type: COMPARATOR
Intervention: Trials with 'nonsignificant' results
Number of subjects: 293
Study 8306005 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis from this and 3 similar studies
Number of subjects: 293
Study 3621989 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine twice daily
Number of subjects: 16
Study 3621989 — intervention group
Group type: COMPARATOR
Intervention: 25 mg mefruside once daily
Number of subjects: 16
Study 3621989 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nifedipine and mefruside
Number of subjects: 16
Study 3621989 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine and mefruside
Number of subjects: 16
Study 30572485 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative celecoxib analgesia
Number of subjects: 226
Study 30572485 — intervention group
Group type: COMPARATOR
Intervention: Postoperative celecoxib analgesia
Number of subjects: 226
Study 30572485 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 226
Study 27217288 — intervention group
Group type: EXPERIMENTAL
Intervention: Very brief intervention for promoting physical activity in primary care (details on dosage and duration not available)
Number of subjects: 16
Study 25385912 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum-chewing (sugarless gum, 3 times daily for 30 min starting 6 hours postoperatively)
Number of subjects: 180
Study 25385912 — intervention group
Group type: COMPARATOR
Intervention: Control (no gum chewing)
Number of subjects: 180
Study 22079797 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg docosahexaenoic acid (G-DHA) daily for 14 days
Number of subjects: 63
Study 22079797 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (G-OO) as placebo for 14 days
Number of subjects: 63
Study 20044087 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg)
Number of subjects: 40
Study 20044087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 18502423 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15787007 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-operated robotic ultrasound system
Number of subjects: 0
Study 11814489 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to consonant-vowel-consonant (CVC) syllables with restrictions on consonant position
Number of subjects: 0
Study 10516451 — intervention group
Group type: EXPERIMENTAL
Intervention: Total PSA in liver cirrhosis patients
Number of subjects: 75
Study 10516451 — intervention group
Group type: EXPERIMENTAL
Intervention: Free/total PSA ratio in liver cirrhosis patients
Number of subjects: 75
Study 10150489 — intervention group
Group type: EXPERIMENTAL
Intervention: Cistinexine dihydrochloride (active drug)
Number of subjects: 30
Study 10150489 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 30
Study 1988827 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-1A (100 mg intravenous dose in 3.5 g of albumin)
Number of subjects: 543
Study 1988827 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3.5 g of albumin)
Number of subjects: 543
Study 6634894 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (20 mg)
Number of subjects: 0
Study 6634894 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 0
Study 31488140 — intervention group
Group type: EXPERIMENTAL
Intervention: Compulsory health-related homework programme
Number of subjects: 675
Study 31488140 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 675
Study 30292597 — intervention group
Group type: EXPERIMENTAL
Intervention: Knotless repair (coreless No. 2 FiberWire interconnected between 3.9‐mm knotless CorkScrew anchors)
Number of subjects: 14
Study 30292597 — intervention group
Group type: COMPARATOR
Intervention: Knotted repair (No. 2 FiberWire double pulley with 3.0‐mm SutureTak anchors)
Number of subjects: 14
Study 27400374 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 800 mg/day for 14 days before surgery
Number of subjects: 45
Study 27400374 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib treatment
Number of subjects: 45
Study 27400374 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NSAID)
Number of subjects: 45
Study 24766239 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised endurance and strength training (EST)
Number of subjects: 31
Study 24766239 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 31
Study 22450001 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet distribution
Number of subjects: 2000
Study 22450001 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention (control) group
Number of subjects: 2000
Study 19214090 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic resonance (SR) stimulation at various intensity levels (0%, 25%, 50%, 90%)
Number of subjects: 18
Study 19214090 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic resonance (SR) stimulation
Number of subjects: 18
Study 17233861 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid access to ultrasound and CA125 test for women with symptoms; no specific dosage or duration mentioned.
Number of subjects: 317
Study 15782501 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive interventions including education of former-smokers and improvement of living environment in interventional villages.
Number of subjects: 34436
Study 15782501 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive interventions in interventional villages.
Number of subjects: 34436
Study 12149108 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg three times a day for 8 weeks)
Number of subjects: 13
Study 12149108 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 13
Study 9834911 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid plus rifampin (300 mg isoniazid + 600 mg rifampin per day for 3 months)
Number of subjects: 196
Study 9834911 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid (300 mg per day for 9 months)
Number of subjects: 196
Study 7666798 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine 0.28 g/kg BW
Number of subjects: 33
Study 7666798 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-ketoglutarate 0.28 g/kg BW
Number of subjects: 33
Study 7666798 — intervention group
Group type: COMPARATOR
Intervention: Control (glucose 2 g/kg BW)
Number of subjects: 33
Study 2760250 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Triclosan/0.5% zinc citrate toothpaste
Number of subjects: 0
Study 2760250 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% chlorhexidine/detergent toothpastes
Number of subjects: 0
Study 2760250 — intervention group
Group type: COMPARATOR
Intervention: 0.2% chlorhexidine rinse
Number of subjects: 0
Study 2760250 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine toothpaste (experimental)
Number of subjects: 0
Study 692847 — intervention group
Group type: EXPERIMENTAL
Intervention: Right-ear speech targets
Number of subjects: 0
Study 692847 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-ear musical targets
Number of subjects: 0
Study 692847 — intervention group
Group type: COMPARATOR
Intervention: Dichotic pairs of music or speech
Number of subjects: 0
Study 30478972 — intervention group
Group type: EXPERIMENTAL
Intervention: Beatalk technique (study group)
Number of subjects: 12
Study 30478972 — intervention group
Group type: COMPARATOR
Intervention: Traditional speech therapy (control group)
Number of subjects: 12
Study 27061732 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate stress during preparation for a medical exam with high-salt intake
Number of subjects: 10
Study 27061732 — intervention group
Group type: COMPARATOR
Intervention: Low stress outside the exam period with high-salt intake
Number of subjects: 10
Study 27061732 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt intake during moderate stress
Number of subjects: 10
Study 25792627 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional hormone therapy
Number of subjects: 60
Study 25792627 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate monthly
Number of subjects: 60
Study 23613481 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence Intervention (AI)
Number of subjects: 30
Study 23613481 — intervention group
Group type: COMPARATOR
Intervention: Treatment‐As‐Usual (TAU)
Number of subjects: 30
Study 20888096 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity progressive resistance training
Number of subjects: 54
Study 20888096 — intervention group
Group type: COMPARATOR
Intervention: Sham-exercise program
Number of subjects: 54
Study 20888096 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity progressive resistance training and Sham-exercise program
Number of subjects: 54
Study 18434881 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation (NIPPV)
Number of subjects: 0
Study 18434881 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium/oxygen gas mixtures
Number of subjects: 0